跳到主要内容
Rallybid

筹划中

RFI: Digital Technologies for Contact Tracing, Infection Surveillance & Response

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency已就“RFI: Digital Technologies for Contact Tracing, Infection Surveillance & Response”发布此招标,现已不再接受新的投标。

此招标已不再接受新的投标。 类似的进行中招标

用通俗的话说,这项招标是什么?

此公告尚未翻译,以原文语言显示。

同类招标的过往中标记录说明了什么?

  • 同类招标平均每项约有 2.6 份投标(132 项中标记录载有数目)。
  • 半数同类合同的中标金额介于 £95,858 至 £861,915,中位数为 £249,480。

根据过去 36 个月 867 项中标记录:相同工种、相同地区。可信程度:高。以上仅反映过往情况,并非预测结果。 中标数据

谁赢得了这项招标,金额是多少?

此招标尚未公布中标结果。

公告全文

原文(English)

RFI: Digital Technologies for Contact Tracing, Infection Surveillance & Response

The UK Health Security Agency (UKHSA) is seeking to understand the market's ability to deliver digital technologies that support public health intervention activities such as, but not limited to, surveillance, infection identification, the management of cases, contacts and exposures during a health emergency. The objective of this Request for Information (RFI) is to inform future preparedness planning and ensure the UK has access to scalable, effective and deployable digital capabilities that can help reduce transmission, improve situational awareness and support public health interventions during a pandemic or other infectious disease emergency. The key dates for this RFI are as follows: RFI Published: 18th September 2026 RFI Response Deadline: 2nd October 2026 Specifically, UKHSA wishes to: I. Understand the current and emerging marketplace for digital technologies that could be deployed during a future pandemic or infectious disease incident to support the prevention, identification, monitoring and management of infection transmission among the population, across a range of pathogens and settings. II. Understand the intended purpose, use cases and operational objectives of technologies currently available or under development, including solutions not specifically designed for pandemic response but which may have utility in supporting infection control measures, population monitoring, exposure identification or public communications during a health emergency. III. Assess the effectiveness, maturity and performance characteristics of different intervention, surveillance and outbreak-management technologies, including evidence of impact, operational limitations and suitability for deployment across diverse settings such as communities, healthcare facilities, care homes, schools and other educational establishments, custodial environments, travel and transportation hubs, and workplaces. IV. Understand the costs associated with the implementation, operation and maintenance of technologies across different deployment scenarios, including infrastructure, licensing, support, integration and user adoption requirements, to inform assessments of affordability and value for money. V. Understand suppliers' manufacturing, delivery and operational capacity (inclusive of lead times), including their ability to rapidly scale deployment during a national emergency, and identify key dependencies, risks, constraints and mitigation approaches that may affect resilience of supply. VI. Assess industry capability to develop, adapt or configure bespoke digital solutions that support activities such as case management, contact tracing, exposure notification, outbreak investigation, provision of personalised advice, and wider population engagement, including the ability to provide interoperable data flows into UKHSA systems in near real time while meeting relevant legal, data protection, security and governance requirements. VII. Refine UKHSA's understanding of requirements by identifying innovative approaches, emerging technologies and alternative delivery models that may improve public health outcomes, operational effectiveness, user experience and scalability for Pandemic and other large scale public health incidents. VIII. Inform UKHSA's future commercial strategy and route-to-market approach, ensuring procurement requirements are proportionate, deliver value for money, maximise competition and innovation, and support the acquisition of capabilities that are fit for purpose during health emergencies. Should you wish to respond to this Request for Information or require more information, please follow the link below: https://atamis-1928--prospend.vf.force.com/apex/CS_ContractPage?filters=&page=1&Preview=Yes&searchStr=&SearchType=Projects&sortStr=Alphabetical&uid=a07Pz00001wm4S4IAI&sfdcIFrameOrigin=https%3A%2F%2Fatamis-1928.lightning.force.com

通过邮件接收这些招标

每天一封邮件,列出你所选行业和地区的新招标。无需账户或密码。

我们会先通过邮件向你发送确认链接。在你使用链接之前,不会发送任何其他内容。 隐私声明

快速解答

这项招标什么时候截止?

公告没有注明截止日期。请查看采购方的门户网站。

这份合同价值多少?

公告没有注明金额。

采购方是谁?

采购方是Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency。

同类招标通常有多少企业投标?

同类招标平均每项约有 2.6 份投标(132 项中标记录载有数目)。 根据过去 36 个月 867 项中标记录:相同工种、相同地区。可信程度:高。以上仅反映过往情况,并非预测结果。

类似的进行中招标